Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study

BACKGROUND: Severity/mortality risk scores and disease characteristics may assist in deciding whether patients with community-acquired bacterial pneumonia (CABP) require outpatient treatment or hospitalization. The phase 3 OPTIC (Omadacycline for Pneumonia Treatment In the Community) study enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Julio, Deck, Daniel H, Eckburg, Paul B, Curran, Marla, Das, Anita F, Kirsch, Courtney, Manley, Amy, Tzanis, Evan, McGovern, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212944/
https://www.ncbi.nlm.nih.gov/pubmed/34160474
http://dx.doi.org/10.1093/ofid/ofab135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212944/
https://www.ncbi.nlm.nih.gov/pubmed/34160474
http://dx.doi.org/10.1093/ofid/ofab135

Ejemplares similares